Veterinary Medicines

NOBILIS AE + POX, liofilizat și solvent pentru suspensie injectabilă

Authorised
  • Avian encephalomyelitis virus, strain Calnek 1143, Live
  • Fowlpox virus, strain GIBBS, Live
Download as PDF

Product identification

Medicine name:
NOBILIS AE + POX, liofilizat și solvent pentru suspensie injectabilă
Active substance:
  • Avian encephalomyelitis virus, strain Calnek 1143, Live
  • Fowlpox virus, strain GIBBS, Live
Target species:
  • Chicken (hen)
  • Turkey (hen)
Route of administration:
  • Intradermal use

Product details

Active substance and strength:
  • Avian encephalomyelitis virus, strain Calnek 1143, Live
    1.80
    log 10 50% embryo infective dose
    /
    0.01
    millilitre(s)
  • Fowlpox virus, strain GIBBS, Live
    1.80
    log 10 50% embryo infective dose
    /
    0.01
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intradermal use
    • Chicken (hen)
      • Meat and offal
        0
        day
    • Turkey (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 150250
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 23/11/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."